Rapamune (Sirolimus Oral Suspension) 1mg/ml x 60ml

Rapamune (sirolimus) oral suspension 1mg/ml x 60ml is an immunosuppressant used to prevent organ transplant rejection. This Canada-sourced liquid formulation offers convenient dosing for post-transplant care. Always follow healthcare provider instructions when using immunosuppressants.

Strength

1mg/ml x 60ml

Manufacturer / TM Owner

Pfizer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sirolimus is primarily used to prevent organ transplant rejection in kidney transplant patients. It belongs to a class of medications called immunosuppressants, which help reduce the activity of the body's immune system. This medication is typically started shortly after transplantation and continued long-term to maintain graft function.

Side Effects

Sirolimus works by blocking specific immune system pathways that would otherwise attack the transplanted organ. Patients may notice improved transplant function over time with consistent use. Some users report mild gastrointestinal effects early in treatment that often lessen as the body adjusts.

Precautions & Warnings

Store Rapamune oral suspension at room temperature away from light and moisture. Keep the medication out of reach of children and pets. Always use the provided oral syringe for accurate dosing. Regular blood tests are important to monitor drug levels and organ function during treatment.

Avoid Interactions

Sirolimus can interact with many medications, including certain antibiotics, antifungals, and cholesterol-lowering drugs. Grapefruit and grapefruit juice may increase sirolimus levels in the blood. Always inform your healthcare provider about all medications and supplements you're taking before starting sirolimus.

Frequently Asked Questions

Sirolimus is an immunosuppressant medication primarily used to prevent organ transplant rejection, especially in kidney transplant patients.

Store Rapamune oral suspension at room temperature, away from light and moisture. Keep it in the original container with the cap tightly closed.

No, grapefruit and grapefruit juice should be avoided while taking sirolimus as they can increase the medication's levels in your blood.

Rapamune oral suspension should be taken once daily at the same time each day, using the provided oral syringe for accurate dosing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.